• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Jawed Zia joins Abbott as VP, Established Pharmaceuticals, India

financialexpressJune 01, 2018

Tag: Jawed Zia , VP , Established Pharmaceuticals

Abbott has appointed Jawed Zia as VP, Established Pharmaceuticals, India. Reportedly, in this role, Zia will lead Abbott’s India pharma business. He will be responsible for Abbott’s continued growth and leadership in the country.

Zia joins Abbott from Novartis where he was the Pharma Division Head of Novartis Pharmaceuticals and Country President. Over the last 25 years of his career, Zia has been in various leadership roles with Novartis, working in its pharma and ophthalmic businesses, as well as being part of many integration projects. He has had the opportunity to work in several countries including Singapore, Turkey and Saudi Arabia.

Register as Visitor to CPhI China 2018!

Previous:Serum Institute of India and Intravacc to develop Bioneedles

Next:Sanofi Genzyme partners with MSSI to support multiple sclerosis community

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Jawed Zia joins Abbott as VP, Established Pharmaceuticals, India | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

PVP K30/K90

PVP K30/K90
PVP K30

PVP K30
NVP BGJ398 phosphate

NVP BGJ398 phosphate
PVP K15-polyvinylpyrrolidone k15

PVP K15-polyvinylpyrrolidone k15
PVP K30

PVP K30
Copovidone PVP / VA64

Copovidone PVP / VA64
PVP K17

PVP K17
  PVP Iodine

  PVP Iodine
Glucosamine Sulfate Potassium Chloride PVP granule DC95

Glucosamine Sulfate Potassium Chloride PVP granule DC95
Glucosamine Sulfate Potassium Chloride DC95% with 5% PVP K-30

Glucosamine Sulfate Potassium Chloride DC95% with 5% PVP K-30

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service